Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response. Read more about Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin. Read more about Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.
Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers. Read more about Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype. Read more about Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update. Read more about Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update.
Response to "CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers". Read more about Response to "CYP2C9 polymorphism is not a major determinant of bosentan exposure in healthy volunteers".
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations. Read more about CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Profiling solute carrier transporters in the human blood-brain barrier. Read more about Profiling solute carrier transporters in the human blood-brain barrier.
Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers. Read more about Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers.
Association of CYP2C9*2 with bosentan-induced liver injury. Read more about Association of CYP2C9*2 with bosentan-induced liver injury.
